Research Correspondence

DOI: 10.4244/EIJ-D-24-00911

Optical coherence tomography versus intravascular ultrasound- guided PCI in patients with and without acute coronary syndrome: a prespecified subanalysis of the OCTIVUS trial

Ju Hyeon Kim1,2, MD, PhD; Soon Jun Hong1, MD, PhD; Subin Lim1, MD, PhD; Jung-Joon Cha1, MD, PhD; Hyung Joon Joo1, MD, PhD; Jae Hyoung Park1, MD, PhD; Cheol Woong Yu1, MD, PhD; Do-Sun Lim1, MD, PhD; Do‐Yoon Kang2, MD, PhD; Jung‐Min Ahn2, MD, PhD; Duk‐Woo Park2, MD, PhD; Seung‐Jung Park2, MD, PhD

The latest European guidelines recommend intracoronary imaging (ICI) guidance by intravascular ultrasound (IVUS) or optical coherence tomography (OCT) for percutaneous coronary intervention (PCI) on anatomically complex lesions, particularly for left main stem, true bifurcations, and long lesions1. However, large-scale randomised studies comparing the efficacy between ICI-guided and angiography-guided PCI in patients with acute coronary syndrome (ACS) remain limited. In patients with non-ST-segment elevation ACS, OCT-guided PCI has been associated with a higher post-PCI fractional flow reserve compared to angiography guidance, providing detailed information on lesion characteristics and stent expansion2. Performing OCT-guided PCI in acute settings poses significant challenges due to the need for blood clearance, which may lead to complications such as slow flow, dissection, and distal embolisation3. We investigated whether OCT offers comparable clinical efficacy and safety to IVUS for patients with and without ACS in an all-comers PCI population.

In this post hoc analysis of the OCTIVUS trial with extended 2-year follow-up, we evaluated the outcomes of OCT versus IVUS guidance for PCI in ACS and non-ACS patients, building upon the initial 1-year non-inferiority findings4....

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 21 Number 10
May 16, 2025
Volume 21 Number 10
View full issue


Key metrics

Suggested by Cory

Flashlight

10.4244/EIJ-D-25-00341 Jan 8, 2026
Retrieval of a stuck transcatheter aortic valve device via left ventricular apex and transapical implantation
Yasuda M et al
open access

Editorial

10.4244/EIJ-E-25-00053 Jan 5, 2026
The quiescent volcanoes that don't harm anymore
Prati F and Biccirè F
free

Editorial

10.4244/EIJ-D-25-01153 Jan 5, 2026
Computed tomography angiography-derived microvascular resistance: is less always more?
Gallinoro E and Barbato E
free

Editorial

10.4244/EIJ-E-25-00051 Jan 5, 2026
QFR in clinical practice: raising the bar for quality and reproducibility
Lansky A
free

Viewpoint

10.4244/EIJ-D-25-01167 Jan 5, 2026
High-risk plaques: intervene early or hold the line?
Mintz G and Collet C
free

Expert Review

10.4244/EIJ-D-25-00263 Jan 5, 2026
Endomyocardial biopsy
Fabris E et al
free

Original Research

10.4244/EIJ-D-25-00648 Jan 5, 2026
Long-term clinical outcomes of non-culprit plaque rupture in STEMI
Zhao J et al

Original Research

10.4244/EIJ-D-25-00671 Jan 5, 2026
Non-invasive assessment of microcirculatory resistance by coronary computed tomography angiography
Deng D et al
open access

Original Research

10.4244/EIJ-D-25-00668 Jan 5, 2026
Repeatability and quality assessment of QFR in the FAVOR III Europe trial: the REPEAT-QFR study
Kristensen S et al
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved